mirabegron

Italy

Drugs containing this active substance

  • BETMIGA

    The medicine is used to treat the symptoms of an overactive bladder in adults (such as urgency to urinate, increased frequency, and incontinence) and to treat neurogenic detrusor overactivity in children aged 3 to 18 years, helping them to hold more urine and reduce leakage.

    Form: tablets, prolonged-release

    Active substance Dosage
    mirabegron -

    ATC: G04BD12

    Manufacturer: ASTELLAS PHARMA EUROPE B.V.

  • It is used to treat symptoms of overactive bladder in adults (such as urgency to urinate, excessive frequency, and incontinence) and for neurogenic detrusor overactivity in children aged 3 years and older.

    Form: tablets, prolonged-release

    Active substance Dosage
    mirabegron -

    ATC: G04BD12

    Manufacturer: ZENTIVA ITALIA S.R.L.

  • It is used to treat the symptoms of overactive bladder syndrome in adults, such as the sudden urge to urinate, the need to urinate more often than normal, and the inability to control bladder emptying.

    Form: tablets, prolonged-release

    Active substance Dosage
    mirabegron -

    ATC: G04BD12

    Manufacturer: DOC GENERICI SRL